cro.directory
← Compare landing

Cyagen Biosciences vs Scantox

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCyagen BiosciencesScantox
SummaryCyagen provides genetically engineered animal models, custom cell lines, and viral packaging services for preclinical research, with specialized expertise in humanized mice, gene therapy vectors, and disease-specific models across oncology, neurology, and metabolic disorders.Preclinical CRO with a CNS/neurology focus, offering in vivo transgenic and induced disease models for Alzheimer's, Parkinson's, ALS, and Huntington's alongside in vitro assays for tau and α-synuclein aggregation, neuroinflammation, and neuronal plasticity.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Translational Research
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • Preclinical In Vivo Studies
  • In Vivo Efficacy Models
  • Specialized & Large-Animal Models
  • Pathology & Histology Services
Modalities
  • Biologics (Monoclonal Antibodies)
  • Oligonucleotide
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Data not yet provided.
Indications
  • Oncology
  • Immunology
  • Neurology
  • Metabolic
  • Rare Disease
  • Ophthalmology
  • Neurology
  • Psychiatry
Phases
  • Discovery
  • Preclinical (General)
  • Preclinical (IND-Enabling)
  • Discovery
  • Preclinical (General)
Sourcing models
  • Full-Service Outsourcing (FSO)
Data not yet provided.
Locations
  • Headquarters, Santa Clara, California, United States
Data not yet provided.
Certifications
  • AAALAC · Identifier: AAALAC-accredited facilities
Data not yet provided.

Find similar companies

Cyagen Biosciences alternatives · Scantox alternatives

Markdown mirror: /compare/apac-cyagen/scantox.md